Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sylvie Bonvalot"'
Publikováno v:
Oncologist
Cystic lymphangioma are rare benign vascular or lymphatic tumors, diagnosed mostly in newborns or children, that may become life‐threatening because of local invasiveness. Surgical “en‐bloc” resection with negative margins is the only curativ
Autor:
Carmela Dantas-Barbosa, Isabelle Ray-Coquard, Tom Lesluyes, Pierre Meeus, Jean-Yves Blay, Antoine Italiano, Pierre Saintigny, Marie-Pierre Sunyach, Hiba El Sayadi, M. Jean-Denis, Mehdi Brahmi, Sylvie Bonvalot, Laurent Alberti, Maud Toulmonde, Axel Le Cesne, Jean-Michel Coindre, Frédéric Chibon, Françoise Ducimetière, Isabelle Treilleux, François Le Loarer, Olivier Mir, Olivia Bally, Dominique Ranchère
Publikováno v:
British Journal of Cancer
Background: Leiomyosarcoma (LMS) are 15% of adult sarcomas and remain seldom curable in metastatic phase. The TAM receptors and their ligands are overexpressed or activated in multiple malignancies, including LMS. Methods: The TAM receptor and ligand
Autor:
Bruno Landi, Société Nationale Française de Gastroentérologie, Société Française de Chirurgie Digestive, Charles Honoré, Eric Lartigau, Marc Pracht, Jean Michel Coindre, Olivier Bouché, Georges Mantion, Mathilde Brasseur, Jean-François Emile, Société Française d’Endoscopie Digestive, Fédération Nationale de Centres de Lutte Contre les Cancers, Société française de radiothérapie oncologique, Sylvie Bonvalot, Vincent Hautefeuille, Axel Le Cesne, Groupe Coopérateur multidisciplinaire en Oncologie, Jean-Yves Blay, Michel Ducreux
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 51(9)
Background This document is a summary of the French Intergroup guidelines regarding the management of gastrointestinal stromal tumours (GISTs) updated in December 2018. Design This collaborative work summarizes clinical practice recommendations (guid
Autor:
Charles Honoré, Sylvie Bonvalot
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 196:855-860
Complete resection without tumor rupture remains the mainstay of treatment for patients with localized, resectable GIST The surgical indications should take into account the size and location of the tumor, both of which influence the risk of recurren
Autor:
Antoine Hakime, Agnès Laplanche, Laurence Drouard-Troalen, Jane Muret, Jean Mendiboure, Angelo Paci, Laure Bonnet, Axel Le Cesne, Thierry de Baere, Philippe Israel, Alexander M.M. Eggermont, Sylvie Bonvalot, Françoise Farace, Guillaume Bonniaud, Bruno Raynard
Publikováno v:
Annals of Surgery. 255:281-286
Purpose To assess the efficacy of isolated pelvic perfusion (IPP) with tumor necrosis factor (TNF)-α and melphalan in patients with locally advanced cancers in the pelvic and groin area requiring mutilating surgery. Methods A total of 27 patients we
Autor:
Angela Cioffi, Jean-Pierre Kinet, Binh Bui, Alain Moussy, Sylvie Bonvalot, Jean-Yves Blay, Julien Domont, Olivier Bouché, Antoine Adenis, Axel Le Cesne, Nathalie Lassau, Isabelle Ray-Coquard, Olivier Hermine
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2010, 46, pp.1344-1351
Eur. J. Cancer
Eur. J. Cancer, 2010, 46, pp.1344-1351
European Journal of Cancer, Elsevier, 2010, 46, pp.1344-1351
Eur. J. Cancer
Eur. J. Cancer, 2010, 46, pp.1344-1351
Background Masitinib is a tyrosine kinase inhibitor with greater in vitro activity and selectivity for the wild-type c-Kit receptor and its juxtamembrane mutation than imatinib, without inhibiting kinases of known toxicities. This phase II study eval
Autor:
Axel Le Cesne, Françoise Rimareix, Philippe Terrier, Jane Muret, Sylvain Causeret, Cécile Le Péchoux, Sylvie Bonvalot, B. Boulet
Publikováno v:
Annals of Surgical Oncology. 16:3350-3357
In a prior randomized phase II trial comparing hyperthermic isolated limb perfusion (HILP) with four different doses of tumor necrosis factor alpha (TNF-alpha), no dose effect was detected for response, but systemic toxicity was far lower with low-do
Autor:
M. Albiter, Clarisse Dromain, Philippe Terrier, Sylvie Bonvalot, Daniel Vanel, Axel Le Cesne, Lorraine G. Shapeero, Mylène Mabille, Cécile Le Péchoux
Publikováno v:
European Journal of Radiology. 69:204-208
Purpose To define computed tomography (CT) criteria for evaluating the response of patients with gastrointestinal stromal tumors (GIST) who are receiving Imatinib (tyrosine-kinase inhibitor therapy). Materials and methods This prospective CT study ev
Publikováno v:
The Oncologist. 11:9-20
The introduction of imatinib, an orally administered inhibitor of the KIT receptor tyrosine kinase, is prompting revision of the management algorithms that have traditionally guided the treatment of gastrointestinal stromal tumor (GIST). Historically
Autor:
Maria Rios, Mehdi Brahmi, Maud Toulmonde, Sylvie Bonvalot, Olivier Mir, Jean-Yves Blay, Antoine Italiano, Maria Debiec-Rychter, Nicolas Isambert, Patrick Schöffski, Sophie Piperno-Neumann, Frédéric Chibon, Jean-Michel Coindre, Axel Le Cesne, Christine Chevreau, Isabelle Ray-Coquard, Raf Sciot, Tom Lesluyes
Publikováno v:
Journal of Clinical Oncology. 35:11067-11067
11067 Background: Sarcomas are a variety of rare connective tissue cancers. Doxorubicin and olaratumab (Ab against PDGFRA) improved survival in a recent Phase 1/2 study. Besides PDGFRA mutated gastrointestinal stroma tumor (GIST) and dermatofibrosarc